Table 2. Associations between serum hs-CRP and the prevalence of type 2 diabetes.
| Serum hs-CRP |
P for trend | |||
|---|---|---|---|---|
| Q1 + Q2 (≤0.31 mg/L) | Q3 (>0.31∼0.66 mg/L) | Q4 (>0.66 mg/L) | ||
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||
| Prevalence rate of diabetes (%) | 3.0 | 6.4 | 10.2 | |
| Model 1 | 1 | 1.7 (0.86, 3.5) | 3.0 (1.6, 5.7) | <0.001 |
| Model 2 | 1 | 1.9 (0.91, 3.8) | 3.2 (1.7, 6.3) | <0.001 |
| Model 3 | 1 | 1.5 (0.68, 3.1) | 2.4 (1.2, 4.8) | 0.015 |
| Model 4 | 1 | 1.5 (0.71, 3.3) | 2.4 (1.2, 4.9) | 0.016 |
hs-CRP, high-sensitivity C-reactive protein; Q2, first quartile; Q3, second quartile; Q4, third quartile; Q1, fourth quartile.
OR, odds ratio; CI, confidence interval.
Model 1: adjusted for age and sex.
Model 2: adjusted for age, sex, recruit group, smoking status, current alcohol drinkings, leisure-time exercise, carbohydrate intake, and energy intake.
Model 3: adjusted for the covariates in model 2 plus body mass index.
Model 4: adjusted for the covariates in model 3 plus family history of diabetes.